DETEKSI DINI GANGGUAN MINERAL TULANG PADA PENYAKIT GINJAL KRONIK: TINJAUAN SISTEMATIK

EARLY DETECTION OF BONE MINERAL DISORDERS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW

  • Agustiawan Fakultas Kedokteran, Institut Kesehatan Helvetia
  • Sugianto Mukmin PAPDI Kalimantan Barat
  • Ekawaty Suryani Mastari Fakultas Kedokteran, Institut Kesehatan Helvetia
  • Amanda Trixie Hardigaloeh PAPDI Kalimantan Barat
  • Denny Susanto Sekolah Tinggi Ilmu Kesehatan Bala Keselamatan

Abstract

Gangguan metabolisme mineral dan tulang merupakan komplikasi penting pada pasien penyakit ginjal kronik yang berdampak pada meningkatnya morbiditas, mortalitas, dan risiko fraktur tulang. Tinjauan sistematik ini bertujuan untuk menganalisis bukti terkini mengenai peran biomarker biokimia dan pemeriksaan radiologis dalam deteksi dini CKD-MBD pada pasien CKD stadium 2–5. Pencarian literatur dilakukan melalui PubMed, Scopus, dan ScienceDirect untuk periode 2015–2025. Empat studi yang memenuhi kriteria inklusi berasal dari India, Italia, Tiongkok, dan Bangladesh, dengan desain potong lintang dan kohort prospektif. Bukti yang kami himpun menunjukkan bahwa peningkatan kadar parathyroid hormone (PTH), fosfat, alkaline phosphatase (ALP), dan fibroblast growth factor-23 (FGF-23) secara konsisten berhubungan dengan penurunan bone mineral density (BMD) serta progresivitas CKD. Kombinasi pemeriksaan biokimia dengan densitometri tulang (DXA) dan pendekatan berbasis machine learning terbukti meningkatkan akurasi diagnosis dini. Oleh karena itu, pemantauan biomarker tersebut dapat menjadi strategi penting dalam deteksi dan pencegahan CKD-MBD secara komprehensif.

References

Jameson J, Fauci A, Kasper D, Hauser S, Longo D, Loscalzo J. Harrison’s Principles of Internal Medicine 20th ed. New York NY, McGraw Hill Education. 2018;

Albanese L, Caliendo G, D’Elia G, Passariello L, Molinari AM, Napoli C, et al. Diagnostic utility of FGF-23 in mineral bone disorder during chronic kidney disease. Journal of circulating biomarkers. 2022;11:1–4.

Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. Jama. 2019;322(13):1294–304.

Mace ML, Lewin E. Frontiers in Bone Metabolism and Disorder in Chronic Kidney Disease. Vol. 13, Metabolites. 2023.

Brandenburg V, Ketteler M. Vitamin D and secondary hyperparathyroidism in chronic kidney disease: a critical appraisal of the past, present, and the future. Nutrients. 2022;14(15):3009.

Pazianas M, Miller PD. Osteoporosis and chronic kidney disease–mineral and bone disorder (CKD-MBD): back to basics. American Journal of Kidney Diseases. 2021;78(4):582–9.

Hustrini NM, Susalit E, Rotmans JI. Prevalence and risk factors for chronic kidney disease in Indonesia: An analysis of the National Basic Health Survey 2018. Journal of global health. 2022 Oct;12:4074.

Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney International Supplements. 2022;12(1):7–11.

Ginsberg C, Ix JH. Diagnosis and Management of Osteoporosis in Advanced Kidney Disease: A Review. American Journal of Kidney Diseases [Internet]. 2022;79(3):427–36. Available from: https://www.sciencedirect.com/science/article/pii/S0272638621007976

Hu J, Ke R, Teixeira W, Dong Y, Ding R, Yang J, et al. Global, regional, and national burden of CKD due to glomerulonephritis from 1990 to 2019: a systematic analysis from the global burden of disease study 2019. Clinical journal of the American Society of Nephrology. 2023;18(1):60–71.

Deng L, Guo S, Liu Y, Zhou Y, Liu Y, Zheng X, et al. Global, regional, and national burden of chronic kidney disease and its underlying etiologies from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021. BMC Public Health. 2025;25(1):636.

Agarwal A, Nath KA. Chapter 18 - Pathophysiology of Chronic Kidney Disease Progression: Organ and Cellular Considerations. In: Kimmel PL, Rosenberg MEBT-CRD (Second E, editors. Academic Press; 2020. p. 263–78. Available from: https://www.sciencedirect.com/science/article/pii/B9780128158760000188

Senan EM, Al-Adhaileh MH, Alsaade FW, Aldhyani THH, Alqarni AA, Alsharif N, et al. Diagnosis of chronic kidney disease using effective classification algorithms and recursive feature elimination techniques. Journal of Healthcare Engineering. 2021;2021.

Yamada S, Nakano T. Role of Chronic Kidney Disease (CKD)–Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD. Journal of atherosclerosis and thrombosis. 2023;30(8):835–50.

Rastogi A, Bhatt N, Rossetti S, Beto J. Management of Hyperphosphatemia in End-Stage Renal Disease: A New Paradigm. Journal of Renal Nutrition [Internet]. 2021;31(1):21–34. Available from: https://www.sciencedirect.com/science/article/pii/S1051227620300522

Habas ES, Eledrisi M, Khan F, Elzouki A-NY. Secondary Hyperparathyroidism in Chronic Kidney Disease: Pathophysiology and Management. Cureus. 2021 Jul;13(7):e16388.

Rodríguez-Ortiz ME, Rodríguez M. Recent advances in understanding and managing secondary hyperparathyroidism in chronic kidney disease. F1000Research. 2020;9.

Pimentel A, Bover J, Elder G, Cohen-Solal M, Ureña-Torres PA. The Use of Imaging Techniques in Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD)—A Systematic Review. Vol. 11, Diagnostics. 2021.

Etta PK, Sharma RK, Gupta A. Study of chronic kidney disease-mineral bone disorders in newly detected advanced renal failure patients: A Hospital-based cross-sectional study. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2017;28(4):874–85.

D’Arrigo G, Mallamaci F, Pizzini P, Leonardis D, Tripepi G, Zoccali C. CKD-MBD biomarkers and CKD progression: an analysis by the joint model. Nephrology Dialysis Transplantation [Internet]. 2023 Apr 1;38(4):932–8. Available from: https://doi.org/10.1093/ndt/gfac212

Li Y, Lou Y, Liu M, Chen S, Tan P, Li X, et al. Machine learning based biomarker discovery for chronic kidney disease-mineral and bone disorder (CKD-MBD). BMC medical informatics and decision making. 2024 Feb;24(1):36.

Sultana N, Begum A, Jesmin T, Mamun A Al, Huque SS, Roy R, et al. Bone Mineral Density and Serum Biochemical Markers in Children with Chronic Kidney Disease. Paediatric Nephrology Journal of Bangladesh [Internet]. 2024;9(1). Available from: https://journals.lww.com/pnjb/fulltext/2024/09010/bone_mineral_density_and_serum_biochemical_markers.2.aspx

Sozen T, Ozisik L, Basaran NC. An overview and management of osteoporosis. Eur J Rheumatol. 2017;4(1):46–56.

Cannata-Andía JB, Martín-Carro B, Martín-Vírgala J, Rodríguez-Carrio J, Bande-Fernández JJ, Alonso-Montes C, et al. Chronic kidney disease—mineral and bone disorders: pathogenesis and management. Calcified tissue international. 2021;108(4):410–22.

Lima F, Monier-Faugere M-C, Mawad H, David V, Malluche HH. FGF-23 and sclerostin in serum and bone of CKD patients. Clinical Nephrology. 2023;99(5):209.

Wani MM, Wani IA. Chronic Kidney Disease –Mineral Bone Disorder (CKD- MBD) – Further Insight at the Indian patients. JMS SKIMS [Internet]. 2019 Dec 19;22(3 SE-Editorial). Available from: https://jmsskims.org/index.php/jms/article/view/500

Aguilar A, Gifre L, Ureña-Torres P, Carrillo-López N, Rodriguez-García M, Massó E, et al. Pathophysiology of bone disease in chronic kidney disease: from basics to renal osteodystrophy and osteoporosis. Frontiers in Physiology [Internet]. 2023;Volume 14-2023. Available from: https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2023.1177829

Asadipooya K, Abdalbary M, Ahmad Y, Kakani E, Monier-Faugere M-C, El-Husseini A. Bone Quality in Chronic Kidney Disease Patients: Current Concepts and Future Directions–Part II. Kidney Diseases. 2021;7(5):359–71.

Isa S, Salihuddin FNBM, Lim V, Hami R, Ismail TST. Metabolomics in Chronic Kidney Disease: The Emerging Role in Detection and Diagnosis of Mineral and Bone Disorders. Journal of Health Science and Medical Research. 2025;20251186.

Salera D, Merkel N, Bellasi A, de Borst MH. Pathophysiology of chronic kidney disease–mineral bone disorder (CKD-MBD): from adaptive to maladaptive mineral homeostasis. Clinical Kidney Journal [Internet]. 2025 Mar 1;18(Supplement_1):i3–14. Available from: https://doi.org/10.1093/ckj/sfae431

Ketteler M, Bover J, Mazzaferro S. Treatment of secondary hyperparathyroidism in non-dialysis CKD: an appraisal 2022s. Nephrology Dialysis Transplantation. 2023;38(6):1397–404.

Published
2026-01-01
How to Cite
Agustiawan, Mukmin, S., Mastari, E. S., Hardigaloeh, A. T., & Susanto, D. (2026). DETEKSI DINI GANGGUAN MINERAL TULANG PADA PENYAKIT GINJAL KRONIK: TINJAUAN SISTEMATIK: EARLY DETECTION OF BONE MINERAL DISORDERS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW. Ibnu Sina: Jurnal Kedokteran Dan Kesehatan - Fakultas Kedokteran Universitas Islam Sumatera Utara, 25(1), 182-190. https://doi.org/10.30743/ibnusina.v25i1.1052
Section
Systematic Review